Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ralph Freedman
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Chemicals & Drugs
Procedures
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
43
Kavanagh, John
37
Edwards, Creighton
33
Kudelka, Andrzej
29
Verschraegen, Claire
26
Platsoucas, Chris
16
Ioannides, Constantin
12
Nash, Michael
11
Melichar, Bohuslav
10
Wharton, Taylor
8
Lenzi, Renato
8
Patenia, Rebecca
8
Gershenson, David
8
Atkinson, Neely
7
Hu, Wei
7
Quadri, Syed
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ralph Freedman (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Schmeler Kathleen M; Vadhan-Raj Saroj; Ramirez Pedro T; Apte Sachin M; Cohen Lorenzo; Bassett Roland L; Iyer Revathy B; Wolf Judith K; Levenback Charles L; Gershenson David M; Freedman Ralph S
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.
Gynecologic oncology 2009;113(2):210-5.
-
2009: Kobayashi Ryuji; Deavers Michael; Patenia Rebecca; Rice-Stitt Travis; Halbe Jeremy; Gallardo Stacie; Freedman Ralph S
14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.
Cancer immunology, immunotherapy : CII 2009;58(2):247-58.
-
2008: Freedman Ralph S; Ma Qing; Wang Ena; Gallardo Stacie T; Gordon Ilyssa O; Shin Jeong Won; Jin Ping; Stroncek David; Marincola Francesco M
Migration deficit in monocyte-macrophages in human ovarian cancer.
Cancer immunology, immunotherapy : CII 2008;57(5):635-45.
-
2007: Freedman Ralph S; Wang Ena; Voiculescu Sonia; Patenia Rebecca; Bassett Roland L; Deavers Michael; Marincola Francesco M; Yang Peiying; Newman Robert A
Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5736-44.
-
2007: Auzenne Edmond; Ghosh Sukhen C; Khodadadian Mojgan; Rivera Belinda; Farquhar David; Price Roger E; Ravoori Murali; Kundra Vikas; Freedman Ralph S; Klostergaard Jim
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
Neoplasia (New York, N.Y.) 2007;9(6):479-86.
-
2007: Freedman Ralph S; Markman Maurie
Food and drug administration expanded access to treatment: implications for oncology patients.
Cancer 2007;109(11):2157-60.
-
2007: Melichar Bohuslav; Patenia Rebecca; Gallardo Stacie; Melicharová Karolina; Hu Wei; Freedman Ralph S
Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines.
Gynecologic oncology 2007;104(3):707-13.
-
2007: Lenzi Renato; Edwards Robert; June Carl; Seiden Michael V; Garcia Michael E; Rosenblum Michael; Freedman Ralph S
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma.
Journal of translational medicine 2007;5():66.
-
2006: Wang X; Fu S; Freedman R S; Liu J; Kavanagh J J
Immunobiology of gestational trophoblastic diseases.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(4):1500-15.
-
2006: Basil Christopher F; Zhao Yingdong; Zavaglia Katia; Jin Ping; Panelli Monica C; Voiculescu Sonia; Mandruzzato Susanna; Lee Hueling M; Seliger Barbara; Freedman Ralph S; Taylor Phil R; Hu Nan; Zanovello Paola; Marincola Francesco M; Wang Ena
Common cancer biomarkers.
Cancer research 2006;66(6):2953-61.
-
2006: Gordon Ilyssa O; Freedman Ralph S
Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1515-24.
-
2006: Wang X; Fu S; Freedman R S; Kavanagh J J
Venous thromboembolism syndrome in gynecological cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():458-71.
-
2006: Wang Xipeng; Deavers Michael; Patenia Rebecca; Bassett Roland L; Mueller Peter; Ma Qing; Wang Ena; Freedman Ralph S
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.
Journal of translational medicine 2006;4():30.
-
2006: Apte Sachin M; Vadhan-Raj Saroj; Cohen Lorenzo; Bassett Roland L; Gordon Ilyssa O; Levenback Charles F; Ramirez Pedro T; Gallardo Stacie T; Patenia Rebecca S; Garcia Michael E; Iyer Revathy B; Freedman Ralph S
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.
Journal of translational medicine 2006;4():16.
-
2005: Wang Xipeng; Wang Ena; Kavanagh John J; Freedman Ralph S
Ovarian cancer, the coagulation pathway, and inflammation.
Journal of translational medicine 2005;3():25.
-
2005: Pappas John; Jung Weon-Ju; Barda Angeliki K; Lin Wan L; Fincke John E; Purev Enkhtuya; Radu Maria; Gaughan John; Helm C William; Hernandez Enrique; Freedman Ralph S; Platsoucas Chris D
Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.
Cellular immunology 2005;234(2):81-101.
-
2005: See H T; Freedman R S; Kudelka A P; Burke T W; Gershenson D M; Tangjitgamol S; Kavanagh J J
Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(2):209-16.
-
2005: Wang Ena; Ngalame Yvonne; Panelli Monica C; Nguyen-Jackson Hoainam; Deavers Michael; Mueller Peter; Hu Wei; Savary Cherylyn A; Kobayashi Ryuji; Freedman Ralph S; Marincola Francesco M
Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):113-22.
-
2005: Hu Wei; Kavanagh John J; Deaver Michael; Johnston Dennis A; Freedman Ralph S; Verschraegen Claire F; Sen Subrata
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Oncology research 2005;15(1):49-57.
-
2004: Donato M L; Aleman A; Champlin R E; Saliba R M; Wharton J T; Burke T W; Bodurka D C; Bevers M W; Levenback C F; Wolf J K; Bast R C; Freedman R S; Ippoliti C; Brewer M; Gajewski J L; Gershenson D M
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.
Bone marrow transplantation 2004;33(12):1219-24.
-
2004: Melichar Bohuslav; Konopleva Marina; Hu Wei; Melicharova Karolina; Andreeff Michael; Freedman Ralph S
Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression.
Gynecologic oncology 2004;93(1):149-54.
-
2004: Borchardt Paul E; Vriesendorp Huibert M; Freedman Ralph S; Quadri Syed M
Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):43-51.
-
2003: Freedman Ralph S; Vadhan-Raj Saroj; Butts Cherie; Savary Cherylyn; Melichar Bohuslav; Verschraegen Claire; Kavanagh John J; Hicks Marshall E; Levy Lawrence B; Folloder Jody K; Garcia Michael E
Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5228-37.
-
2003: Hu Wei; Wu WeiGuo; Verschraegen Claire F; Chen Ling; Mao Li; Yeung Sai-Ching Jim; Kudelka Andrzej P; Freedman Ralph S; Kavanagh John J
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
Proteomics 2003;3(10):1904-11.
-
2003: Melichar B; Savary C A; Patenia R; Templin S; Melicharova K; Freedman R S
Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(4):435-43.
-
2003: Platsoucas Chris D; Fincke John E; Pappas John; Jung Weon-Ju; Heckel Mark; Schwarting Roland; Magira Eleni; Monos Dimitri; Freedman Ralph S
Immune responses to human tumors: development of tumor vaccines.
Anticancer research 2003;23(3A):1969-96.
-
2003: Melichar Bohuslav; Lenzi Renato; Rosenblum Michael; Kudelka Andrzej P; Kavanagh John J; Melicharova Karolina; Templin Stacie; Garcia Michael E; Abbruzzese James L; Freedman Ralph S
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(3):270-6.
-
2003: Verschraegen Claire F; Hu Wei; Du Yu; Mendoza John; Early Janet; Deavers Michael; Freedman Ralph S; Bast Robert C; Kudelka Andrzej P; Kavanagh John J; Giovanella Beppino C
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):845-52.
-
2002: Lenzi Renato; Rosenblum Michael; Verschraegen Claire; Kudelka Andrzej P; Kavanagh John J; Hicks Marshall E; Lang Eric A; Nash Michael A; Levy Lawrence B; Garcia Michael E; Platsoucas Chris D; Abbruzzese James L; Freedman Ralph S
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3686-95.
-
2002: Gordinier M E; Kudelka A P; Kavanagh J J; Wharton J T; Freedman R S
Thiotepa in combination with cisplatin for primary epithelial ovarian cancer: a phase II study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(6):710-4.
-
2002: Vadhan-Raj Saroj; Kavanagh John J; Freedman Ralph S; Folloder Jody; Currie Laura M; Bueso-Ramos Carlos; Verschraegen Claire F; Narvios Aida B; Connor Jerome; Hoots William K; Broemeling Lyle D; Lichtiger Benjamin
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Lancet 2002;359(9324):2145-52.
-
2002: Nash Michael A; Deavers Michael T; Freedman Ralph S
The expression of decorin in human ovarian tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1754-60.
-
2002: Hwu Patrick; Freedman Ralph S
The immunotherapy of patients with ovarian cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(3):189-201.
-
2002: Hu Wei; Wu Weiguo; Yeung Sai-Ching Jim; Freedman Ralph S; Kavanagh John J; Verschraegen Claire F
Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Anticancer research 2002;22(2A):665-72.
-
2002: Hu Wei; Verschraegen C F; Wu W G; Nash M; Freedman R S; Kudelka A; Kavanagh J J
Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(2):202-7.
-
2001: Zavadova E; Savary C A; Templin S; Verschraegen C F; Freedman R S
Maturation of dendritic cells from ovarian cancer patients.
Cancer chemotherapy and pharmacology 2001;48(4):289-96.
-
2001: Donato M L; Gershenson D M; Wharton J T; Ippoliti C M; Aleman A S; Bodurka-Bevers D; Bevers M W; Burke T W; Levenback C F; Wolf J K; Freedman R S; Bast R C; Gajewski J L; Champlin R E
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Gynecologic oncology 2001;82(3):420-6.
-
2001: Azevedo P; Verschraegen C F; Kavanagh J J; Kudelka A P; Freedman R S; Lu K; Deavers M T
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
European journal of gynaecological oncology 2001;22(5):319-21.
-
2000: Freedman R S; Kudelka A P; Kavanagh J J; Verschraegen C; Edwards C L; Nash M; Levy L; Atkinson E N; Zhang H Z; Melichar B; Patenia R; Templin S; Scott W; Platsoucas C D
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2268-78.
-
2000: Hu W; Wu W; Nash M A; Freedman R S; Kavanagh J J; Verschraegen C F
Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Anticancer research 2000;20(2A):729-33.
-
2000: Vadhan-Raj S; Verschraegen C F; Bueso-Ramos C; Broxmeyer H E; Kudelkà A P; Freedman R S; Edwards C L; Gershenson D; Jones D; Ashby M; Kavanagh J J
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Annals of internal medicine 2000;132(5):364-8.
-
2000: Borchardt P E; Quadri S M; Freedman R S; Vriesendorp H M
Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.
Cancer biotherapy & radiopharmaceuticals 2000;15(1):53-64.
-
2000: Melichar B; Nash M A; Lenzi R; Platsoucas C D; Freedman R S
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Clinical and experimental immunology 2000;119(1):19-27.
-
1999: Nash M A; Loercher A E; Freedman R S
In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin.
Cancer research 1999;59(24):6192-6.
-
1999: Loercher A E; Nash M A; Kavanagh J J; Platsoucas C D; Freedman R S
Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(11):6251-60.
-
1999: Gordinier M E; Zhang H Z; Patenia R; Levy L B; Atkinson E N; Nash M A; Katz R L; Platsoucas C D; Freedman R S
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2498-505.
-
1999: Verschraegen C F; Gupta E; Loyer E; Kavanagh J J; Kudelka A P; Freedman R S; Edwards C L; Harris N; Steger M; Steltz V; Giovanella B C; Stehlin J S
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
Anti-cancer drugs 1999;10(4):375-83.
-
1999: Nash M A; Ferrandina G; Gordinier M; Loercher A; Freedman R S
The role of cytokines in both the normal and malignant ovary.
Endocrine-related cancer 1999;6(1):93-107.
-
1999: Zavadova E; Loercher A; Verstovsek S; Verschraegen C F; Micksche M; Freedman R S
The role of macrophages in antitumor defense of patients with ovarian cancer.
Hematology/oncology clinics of North America 1999;13(1):135-44, ix.
-
1998: Melichar B; Ferrandina G; Verschraegen C F; Loercher A; Abbruzzese J L; Freedman R S
Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3069-76.
-
1998: Nash M A; Lenzi R; Platsoucas C D; Freedman R S
RT-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during bioimmunotherapy.
Journal of immunological methods 1998;219(1-2):169-79.
-
1998: Kudelka A P; Lenzi R; Atkinson E N; Levy L B; Freedman R S
Is ascitic fluid interleukin-12 an independent prognostic factor in ovarian cancer? The necessity of correction milligram P values for multiple comparisons.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3208-9.
-
1998: Freedman R S; Lenzi R; Kudelka A P; Lawrence D D; Rosenblum M; Platsoucas C D
Intraperitoneal immunotherapy of peritoneal carcinomatosis.
Cytokines, cellular & molecular therapy 1998;4(2):121-40.
-
1998: Kudelka A P; Hasenburg A; Verschraegen C F; Edwards C L; Meyers C A; Varma D; Freedman R S; Forman A; Conrad C A; Grove W; Grothey A; Kavanagh J J
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma.
Anti-cancer drugs 1998;9(5):405-9.
-
1998: Nash M A; Lenzi R; Edwards C L; Kavanagh J J; Kudelka A P; Verschraegen C F; Platsoucas C D; Freedman R S
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Clinical and experimental immunology 1998;112(2):172-80.
-
1998: Melichar B; Savary C; Kudelka A P; Verschraegen C; Kavanagh J J; Edwards C L; Platsoucas C D; Freedman R S
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):799-809.
-
1998: Borchardt P E; Quadri S M; Freedman R S; Vriesendorp H M
Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(3):476-84.
-
1998: Verschraegen C F; Natelson E A; Giovanella B C; Kavanagh J J; Kudelka A P; Freedman R S; Edwards C L; Ende K; Stehlin J S
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor.
Anti-cancer drugs 1998;9(1):36-44.
-
1998: Savary C A; Grazziutti M L; Melichar B; Przepiorka D; Freedman R S; Cowart R E; Cohen D M; Anaissie E J; Woodside D G; McIntyre B W; Pierson D L; Pellis N R; Rex J H
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients.
Cancer immunology, immunotherapy : CII 1998;45(5):234-40.
-
1997: Ferrandina G; Melichar B; Loercher A; Verschraegen C F; Kudelka A P; Edwards C L; Scambia G; Kavanagh J J; Abbruzzese J L; Freedman R S
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Cancer research 1997;57(19):4309-15.
-
1997: Kudelka A P; Levy T; Verschraegen C F; Edwards C L; Piamsomboon S; Termrungruanglert W; Freedman R S; Kaplan A L; Kieback D G; Meyers C A; Jaeckle K A; Loyer E; Steger M; Mante R; Mavligit G; Killian A; Tang R A; Gutterman J U; Kavanagh J J
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1501-5.
-
1997: Borchardt P E; Quadri S M; Freedman R S; Vriesendorp H M
Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(3):283-93.
-
1997: Kudelka A P; Winn R; Edwards C L; Downey G; Greenberg H; Dakhil S R; Freedman R S; LoCoco S; Umbreit J; Delmore J E; Arbuck S; Loyer E; Gacrama P; Fueger R; Kavanagh J J
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Anti-cancer drugs 1997;8(7):657-61.
-
1997: Kudelka A P; Siddik Z H; Tresukosol D; Edwards C L; Freedman R S; Madden T L; Rastogi R; Hord M; Kim E E; Tornos C; Mante R; Kavanagh J J
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
Anti-cancer drugs 1997;8(7):649-56.
-
1997: Verschraegen C F; Levy T; Kudelka A P; Llerena E; Ende K; Freedman R S; Edwards C L; Hord M; Steger M; Kaplan A L; Kieback D; Fishman A; Kavanagh J J
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):625-31.
-
1996: Kooi S; Zhang H Z; Patenia R; Edwards C L; Platsoucas C D; Freedman R S
HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
Cellular immunology 1996;174(2):116-28.
-
1996: Freedman R S; Gibbons J A; Giedlin M; Kudelka A P; Kavanagh J J; Edwards C L; Carrasco C H; Nash M A; Platsoucas C D
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):443-51.
-
1996: Vriesendorp H M; Quadri S M; Jaeckle K A; Freedman R S; Cromeens D M
Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;41(2):151-61.
-
1996: Piamsomboon S; Termrungruanglert W; Kudelka A P; Edwards C L; Freedman R S; Mountain C F; Delclos L; Aapro M S; DeCaro L; Bianca J; Verschraegen C F; Kavanagh J J
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
Anti-cancer drugs 1996;7(7):800-4.
-
1996: Quadri S M; Malik A B; Chu H B; Freedman R S; Vriesendorp H M
Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1545-51.
-
1996: Kudelka A P; Winn R; Edwards C L; Downey G; Greenberg H; Dakhil S R; Freedman R S; Loyer E; Rusinkiewicz J; Gacrama P; Fueger R; Kavanagh J J
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1285-8.
-
1996: Verschraegen C F; Kudelka A P; Termrungruanglert W; de Leon C G; Edwards C L; Freedman R S; Kavanagh J J; Vadhan-Raj S
Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1609-11.
-
1996: Freedman R S; Platsoucas C D; Deisseroth A B
Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study.
Human gene therapy 1996;7(11):1351-65.
-
1996: Kudelka A P; Verschraegen C F; Levy T; Edwards C L; Fishman A; Freedman R S; Kaplan A; Kieback D G; Mante R; Ende K; Steger M; Kavanagh J J
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
Anti-cancer drugs 1996;7(4):398-401.
-
1996: Fishman A; Kudelka A P; Tresukosol D; Edwards C L; Freedman R S; Kaplan A L; Girtanner R E; Kavanagh J J
Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor.
The Journal of reproductive medicine 1996;41(6):393-6.
-
1996: Kavanagh J J; Kudelka A P; de Leon C G; Tresukosol D; Hord M; Finnegan M B; Kim E E; Varma D; Forman A; Cohen P; Edwards C L; Freedman R S; Verschraegen C F
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):837-42.
-
1996: Kudelka A P; Tresukosol D; Edwards C L; Freedman R S; Levenback C; Chantarawiroj P; Gonzalez de Leon C; Kim E E; Madden T; Wallin B; Hord M; Verschraegen C; Raber M; Kavanagh J J
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1552-7.
-
1996: Kudelka A P; Tresukosol D; Gonzalez de Leon C; Termrungruanglert W; Edwards C L; Freedman R S; Tornos C; Kavanagh J J
Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1996;79(4):240-5.
-
1996: Lin Y C; Kudelka A P; Lawrence D; Verschraegen C F; Kavanagh J J; Edwards C L; Mante R; Freedman R S
Transcatheter arterial embolization for the control of life-threatening pelvic hemorrhage in a patient with locally advanced cervix carcinoma.
European journal of gynaecological oncology 1996;17(6):480-3.
-
1996: Freedman R S; Platsoucas C D
Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes.
Cancer treatment and research 1996;82():115-46.
-
1996: Tresukosol D; Kudelka A P; Gonzales de Leon C; Edwards C L; Freedman R S; Mante R; Hord M; Kavanagh J J
Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancer.
European journal of gynaecological oncology 1996;17(3):188-91.
-
1995: Quadri S M; Malik A B; Tang X Z; Patenia R; Freedman R S; Vriesendorp H M
Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.
Cancer research 1995;55(23 Suppl):5736s-5742s.
-
1995: Nash M A; Platsoucas C D; Wong B Y; Wong P M; Cottler-Fox M; Otto E; Freedman R S
Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
Human gene therapy 1995;6(11):1379-89.
-
1995: Kavanagh J J; Edwards C L; Freedman R S; Finnegan M B; Balat O; Tresukosol D; Burk K; Loechner S; Hord M; Franklin J L
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer.
Gynecologic oncology 1995;58(1):106-9.
-
1994: Coleman R L; Keeney E D; Freedman R S; Burke T W; Eifel P J; Rutledge F N
Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
Gynecologic oncology 1994;55(1):29-35.
-
1994: Freedman R S; Edwards C L; Kavanagh J J; Kudelka A P; Katz R L; Carrasco C H; Atkinson E N; Scott W; Tomasovic B; Templin S
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):198-210.
-
1994: Vadhan-Raj S; Kudelka A P; Garrison L; Gano J; Edwards C L; Freedman R S; Kavanagh J J
Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):707-14.
-
1994: Freedman R S; Tomasovic B; Templin S; Atkinson E N; Kudelka A; Edwards C L; Platsoucas C D
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.
Journal of immunological methods 1994;167(1-2):145-60.
-
1994: Chen P F; Freedman R S; Chernajovsky Y; Platsoucas C D
Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
Human antibodies and hybridomas 1994;5(3-4):131-42.
-
1993: Kooi S; Freedman R S; Rodriguez-Villanueva J; Platsoucas C D
Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Lymphokine and cytokine research 1993;12(6):429-37.
-
1993: Ioannides C G; Fisk B; Pollack M S; Frazier M L; Taylor Wharton J; Freedman R S
Cytotoxic T-cell clones isolated from ovarian tumour infiltrating lymphocytes recognize common determinants on non-ovarian tumour clones.
Scandinavian journal of immunology 1993;37(4):413-24.
-
1992: Freedman R S; Ioannides C G; Mathioudakis G; Platsoucas C D
Novel immunologic strategies in ovarian carcinoma.
American journal of obstetrics and gynecology 1992;167(5):1470-8.
-
1992: Ioannides C G; Fisk B; Tomasovic B; Pandita R; Aggarwal B B; Freedman R S
Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes.
Cancer immunology, immunotherapy : CII 1992;35(2):83-91.
-
1991: Fromm G L; Freedman R S; Fritsche H A; Atkinson E N; Scott W
Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors.
Cancer 1991;68(9):1885-9.
-
1991: Ioannides C G; Freedman R S
Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumor-associated lymphocytes.
Anticancer research 1991;11(5):1919-25.
-
1991: Ioannides C G; Rashed S; Fisk B; Fan D; Itoh K; Freedman R S
Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
Lymphokine and cytokine research 1991;10(4):307-15.
-
1991: Ioannides C G; Platsoucas C D; Rashed S; Wharton J T; Edwards C L; Freedman R S
Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Cancer research 1991;51(16):4257-65.
-
1991: Burke T W; Stringer C A; Morris M; Freedman R S; Gershenson D M; Kavanagh J J; Edwards C L
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Gynecologic oncology 1991;40(3):264-7.
-
1991: Ioannides C G; Freedman R S; Platsoucas C D; Rashed S; Kim Y P
Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(5):1700-7.
-
1991: Freedman R S; Ioannides C G; Tomasovic B; Patenia R; Zhang H Z; Liang J C; Edwards C L
Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignancies.
Hybridoma 1991;10(1):21-33.
-
1991: Ioannides C G; Freedman R S; Patenia R; Bowen J M; Ward N E; O'Brian C A
Immunological effects of tumor vaccines: III. Influenza virus oncolysates inhibit the TPA induced activation of peripheral blood mononuclear cells.
In vivo (Athens, Greece) 1991;5(1):1-6.
-
1991: Ioannides C G; Freedman R S
T cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy.
International reviews of immunology 1991;7(4):349-64.
-
1990: Riley L B; Pellis N R; Schantz S P; Freedman R S; Balch C M; Itoh K
Humoral modulation of lymphokine-activated killer (LAK)-cell induction in humans: IgG-related and non-IgG inhibitors in sera from cancer patients.
International journal of cancer. Journal international du cancer 1990;46(5):785-91.
-
1990: Sandles L G; Freedman R S; Raber M N; Kavanagh J; Edwards C L; Scott W R; Wharton J T
Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.
Gynecologic oncology 1990;39(2):139-45.
-
1990: Ioannides C G; Freedman R S; Liskamp R M; Ward N E; O'Brian C A
Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C.
Cellular immunology 1990;131(1):242-52.
-
1990: Ioannides C G; Platsoucas C D; Patenia R; Kim Y P; Bowen J M; Morris M; Edwards C; Wharton J T; Freedman R S
T-cell functions in ovarian cancer patients treated with viral oncolysates: I. Increased helper activity to immunoglobulins production.
Anticancer research 1990;10(3):645-53.
-
1990: Ioannides C G; Platsoucas C D; Freedman R S
Immunological effects of tumor vaccines: II. T cell responses directed against cellular antigens in the viral oncolysates.
In vivo (Athens, Greece) 1990;4(1):17-24.
-
1990: Lotzová E; Savary C A; Freedman R S; Edwards C L; Morris M
Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.
Cancer immunology, immunotherapy : CII 1990;31(3):169-75.
-
1989: Tatman J L; Freedman R S; Scott W; Atkinson E N
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
European journal of cancer & clinical oncology 1989;25(11):1619-21.
-
1989: Ioannides C G; Freedman R S; Platsoucas C D
OKT4 monoclonal antibody-induced activation of an autoreactive T-cell clone.
Cellular immunology 1989;123(1):244-52.
-
1989: Freedman R S; Bowen J M; Atkinson E N; Wallace S; Lotzová E; Silva E; Edwards C L; Delclos L; Scott W; Patenia B
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinoma.
American journal of clinical oncology 1989;12(3):244-50.
-
1989: Ioannides C G; Platsoucas C D; O'Brian C A; Patenia R; Bowen J M; Wharton J T; Freedman R S
Viral oncolysates in cancer treatment: immunological mechanisms of action (review).
Anticancer research 1989;9(3):535-44.
-
1989: Gershenson D M; Wharton J T; Copeland L J; Stringer C A; Edwards C L; Kavanagh J J; Freedman R S
Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide.
Gynecologic oncology 1989;32(3):336-41.
-
1989: Ioannides C G; Platsoucas C D; Bowen J M; Wharton J T; Freedman R S
Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatment.
Anticancer research 1989;9(1):81-6.
-
1989: Freedman R S; Kouttab N M; Bowen J M; Edwards C L; Katz R L
Lymphokine activity in malignant effusions after intracavitary viral oncolysate.
Lymphokine research 1989;8(2):115-22.
-
1989: Furukawa K; Lotzová E; Freedman R S; Bowen J B; Edwards C L; Wharton J T
Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer.
Cancer immunology, immunotherapy : CII 1989;30(2):126-32.
-
1988: Lotzová E; Savary C A; Freedman R S; Edwards C L; Wharton J T
Recombinant IL-2-activated NK cells mediate LAK activity against ovarian cancer.
International journal of cancer. Journal international du cancer 1988;42(2):225-31.
-
1988: Kong J S; Peters L J; Wharton J T; Ang K K; Delclos L; Gershenson D M; Copeland L J; Edwards C L; Freedman R S; Saul P B
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity.
International journal of radiation oncology, biology, physics 1988;14(4):737-43.
-
1988: Freedman R S; Edwards C L; Bowen J M; Lotzova E; Katz R; Lewis E; Atkinson N; Carsetti R
Viral oncolysates in patients with advanced ovarian cancer.
Gynecologic oncology 1988;29(3):337-47.
Sign-in to see more
